Keratosis Pilaris: A Nutrition and Natural-Health Reference
Definition and Clinical Presentation
Keratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of the skin. It is a highly prevalent, benign disorder of follicular keratinization characterized by rough keratotic papules and variable perifollicular erythema, most commonly affecting the extensor upper arms, thighs, and buttocks. The tiny papules give the skin a stippled, gooseflesh-like appearance. Clinically, KP presents as multiple small greyish-white, follicular keratotic papules resembling gooseflesh with variable degrees of perifollicular erythema; these papules usually contain fine-coiled, brittle hairs. Lesions are usually asymptomatic but may be itchy, and the extensor aspects of the arms, thighs, face, buttocks, and eyebrows are the most commonly affected sites.
The consequences of KP disease are mainly triggered by dryness and rough skin, which results in bumpy skin, redness, irritation, itching, and hyperpigmentation. Although medically harmless, KP is frequently associated with cosmetic distress, reduced self-confidence, and persistent dissatisfaction with skin texture and appearance. The psychosocial impact of KP is complex and can be associated with developmental issues of body image, socialisation, and sexuality, particularly in the younger adolescent population. There is little documentation covering the extent of these issues, and hence the impact of KP may be underestimated.
Clinical Variants
Keratosis pilaris is a common skin disorder comprising less common variants and rare subtypes, including keratosis pilaris rubra, erythromelanosis follicularis faciei et colli, and the spectrum of keratosis pilaris atrophicans. Keratosis pilaris simplex results in gray and keratotic papules mainly on the arms, thighs, and buttocks; it mainly affects women. Keratosis pilaris rubra often results in keratosis pilaris atrophicans. Common variants include ulerythema ophryogenes, atrophoderma vermiculata, and Siemens alopecia.
Epidemiology
Keratosis pilaris is a common dermatologic condition. The most common patient population is adolescents, with 50 to 80 percent affected. The disorder is also frequently seen in adults, with 40 percent of the adult population affected. However, because keratosis pilaris is an underreported condition, the prevalence of the condition may be higher. Both sexes are affected by KP, but females may be affected more frequently than males. Age of onset is in the first decade of life, and symptoms may worsen during puberty. KP frequently improves by age 30.
The onset of KP often occurs within the first decade of life: an estimated 51% of cases are diagnosed during this period, with 35% during the second decade, 12% during the third, and 2% during the fourth. Symptoms particularly intensify during puberty. Seasonal variation is sometimes described, with improvement of symptoms in summer months. Dry skin in winter tends to worsen symptoms for some groups of patients.
Body Systems Involved
The Integumentary System and Pilosebaceous Unit
Histopathologic, genomic, and epidemiologic evidence points to keratosis pilaris as a primary disorder of the pilosebaceous unit as a result of inherited mutations or acquired disruptions in various biomolecular pathways. The fundamental pathological process involves follicular hyperkeratosis with retention keratosis and abnormal desquamation, often occurring in the context of xerosis and epidermal barrier dysfunction, including associations with atopic dermatitis, ichthyosis vulgaris, and filaggrin-related barrier impairment.
The identification of loss-of-function mutations in the structural protein filaggrin as a widely replicated major risk factor for atopic eczema and associated conditions β including ichthyosis vulgaris and keratosis pilaris β suggests that the primary pathogenetic mechanism in KP is an epithelial barrier abnormality. Much is still unknown about the sequence of biologic, physicochemical, and aberrant regulatory events leading to the clinical manifestations of KP. It is proposed to be a disorder of keratinocytes caused by a mutation in the FLG gene, which codes for filaggrin and is responsible for inducing both hyperkeratosis and inflammatory changes.
The Immune System
KP can be associated with atopy, obesity, and conditions like ichthyosis vulgaris. Atopic dermatitis (AD) is closely linked with KP due to overlaps in certain genetic mutations, with the barrier abnormalities caused by KP possibly enabling the development of AD. In cross-sectional research, keratosis pilaris was associated with a history of atopy (odds ratio 2.80; p<0.01).
Ras Signaling and Molecular Pathways
Recent data highlight aberrant Ras signaling as an important contributor to the pathophysiology of keratosis pilaris and its subtypes. Similar to the etiology, there is no well-established pathophysiology of keratosis pilaris, and data, and critical analysis of existing data, are lacking, so the etiologies, pathogeneses, disease associations, and treatments of these clinical entities are poorly understood.
Contributing and Associated Factors
Genetic Factors
Approximately 30β50% of patients have a positive family history. Autosomal dominant inheritance with variable penetrance has been described. Of those affected, 50β70% have a genetic predisposition. The autosomal recessive form of keratosis pilaris atrophicans is related to a desmoglein 4 mutation.
Keratosis pilaris is a common inherited disorder which has been associated with filaggrin (FLG) loss-of-function mutations, atopic dermatitis (AD), and ichthyosis vulgaris. Keratosis pilaris was significantly associated with palmar hyperlinearity (p < 0.000; OR 4.664) and the filaggrin loss-of-function mutation 2282del4 (p < 0.000; OR 4.917) in a Finnish cross-sectional study of 502 patients with atopic dermatitis. Filaggrin mutations are present in up to 30% of patients with atopic dermatitis and may also predispose patients to ichthyosis vulgaris, allergic rhinitis, and keratosis pilaris.
Some authors found cases of KP associated with chromosome 18p deletion, which may be related to an alteration in the functioning of the LAMA1 gene located on this chromosome. LAMA1 codifies laminin alpha, which is present in cutaneous annexes and seems to be important in forming sebaceous glands.
Associated Skin and Atopic Conditions
Although no clear etiology has been defined, KP is often described in association with other dry-skin conditions such as ichthyosis vulgaris, xerosis, and, less commonly, atopic dermatitis, including conditions related to asthma and allergies. The frequency of KP is increased in individuals with ichthyosis vulgaris and has been estimated at 74%.
Obesity and Metabolic Factors
Keratosis pilaris, a widely prevalent condition, has been linked to increased body mass index (BMI). Observational studies have demonstrated a high prevalence of KP in populations with metabolic dysregulation, with rates of 42% to 64.7% reported in obese cohorts.
In a study of 103 children and adolescents with obesity, skin affections were linearly associated with increasing BMI and higher age. The most common skin findings included keratosis pilaris (64.7%) and acanthosis nigricans (45.0%). The HOMA score (a measure of insulin resistance) was significantly associated with keratosis pilaris (P = 0.019). Other studies, however, did not find a significant link between KP and insulin levels, highlighting inconsistencies in the existing indirect evidence. The principal finding of a 2025 systematic review was the definitive lack of direct evidence on this topic, which constitutes a critical research gap.
Hormonal Factors
Since estrogen increases keratin growth, flares may occur with hormonal changes during puberty or pregnancy. Exacerbations and remissions may occur with times of hormonal change such as pregnancy. Keratosis pilaris is a genetic disorder and can also occur in association with other hereditary diseases such as Noonan syndrome or vitamin disorders.
Medication-Associated KP
A comprehensive review of the literature in PubMed, EMBASE, and CINAHL databases aimed to provide a summary of the clinical characteristics and pathophysiology of keratosis pilaris and its subtypes through the lens of disease associations, genetics, and pharmacologic etiologies. Certain systemic medications have been documented in association with KP-like eruptions; however, such pharmacologic triggers are outside the nutritional scope of this article.
Nutritional Associations
Vitamin A (Retinol)
A nutritional deficit, especially in vitamin A deficiency, can cause phrynoderma, where the skin can exhibit keratin plugs and hyperkeratosis of the hair follicles, atrophy, and squamous metaplasia of the sebaceous glands. Severe vitamin A deficiency causes a condition called phrynoderma, which resembles keratosis pilaris but is more widespread and is associated with other signs of malnutrition.
Phrynoderma, meaning "toad skin," is a type of follicular keratosis coined and described by Nicholls in 1933. Various nutritional deficiencies such as vitamin A, vitamin B-complex, vitamin E, and essential fatty acid (EFA) deficiency, as well as protein-calorie malnutrition, have been suggested as possible etiological factors of phrynoderma. However, the etiology of the disease is still controversial. Most of the studies on phrynoderma were conducted in the early and middle of the last century.
Nutrient deficiencies, particularly in vitamin A, can impair keratinocyte differentiation and worsen follicular plugging. Vitamin A regulates the genes responsible for normal skin cell maturation, and its absence leads to excessive keratin production and abnormal follicle architecture.
Dry skin, keratotic follicular papules, and a higher risk for keratosis pilaris are characteristic of vitamin A deficiency. It is critical to distinguish between true KP β which is primarily genetic β and phrynoderma (nutritional follicular hyperkeratosis), which occurs in the specific context of documented malnutrition. These are related but distinct entities, and the shared morphology does not imply that dietary vitamin A supplementation will alter genetically-determined KP in well-nourished individuals.
Essential Fatty Acids (Omega-3 and Omega-6)
Other nutritional deficiencies associated with the skin changes characteristic of keratosis pilaris include vitamin C deficiency and essential fatty acid deficiency. Vitamin C is vital in maintaining skin health and the differentiation of keratinocytes, while omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) play a critical role in normal skin appearance and function.
Deficiencies in essential fatty acids, particularly omega-3s, can impair skin barrier function and worsen follicular keratinization. Omega-6 and omega-3 essential fatty acids regulate potent signaling molecules called eicosanoids, which influence the inflammatory response in the skin.
The evidence base for omega-3s specifically in KP is weak. No studies have looked at the role of omega-3 and omega-6 in keratosis pilaris development or treatment. What is established is that deficiency of essential fatty acids β in the broader context of malnutrition or malabsorption β can produce or exacerbate follicular hyperkeratosis, as documented in phrynoderma research.
Vitamin E
Many investigators over the past several decades proposed deficiencies of various nutrients like vitamin A, vitamin B complex, essential fatty acids, and vitamin E as possible aetiological factors in phrynoderma (follicular hyperkeratosis). A synergism between vitamins A and E has been explored in follicular keratinization disorders. A synergism between vitamins A and E has been demonstrated by a number of investigators, notably Stanley R. Ames, who showed that in rats on a vitamin E deficient diet, the serum vitamin A level remained low no matter how much vitamin A was given orally or by injection, but that adding vitamin E to the diet restored the vitamin A serum level to normal. This combination was utilized with a high degree of success in three dermatologic conditions involving a defect in keratinization β keratosis follicularis (Darier's disease), pityriasis rubra pilaris, and acne vulgaris β where vitamin A alone had failed to control the conditions. It was proposed that additional dermatoses characterized by dyskeratosis or hyperkeratosis might also benefit. These are older case-report-level observations and were not conducted specifically in KP.
Vitamin C
Vitamin C is vital in maintaining skin health and the differentiation of keratinocytes, while omega-6 and omega-3 polyunsaturated fatty acids play a critical role in normal skin appearance and function. Vitamin C deficiency has been listed alongside vitamin A and essential fatty acid deficiency as a nutritional association with KP-like skin changes, but no clinical trials specifically evaluating vitamin C supplementation for genetically-determined KP have been identified in the peer-reviewed literature.
Phrynoderma: The Nutritional Follicular Hyperkeratosis β Key Distinction
A fundamental distinction must be maintained between primary (genetic) keratosis pilaris and phrynoderma, a nutritional follicular hyperkeratosis. Vitamin A deficiency causes phrynoderma, where the skin can exhibit keratin plugs and hyperkeratosis of the hair follicles, atrophy, and squamous metaplasia of the sebaceous glands. These two conditions share morphological overlap. In the treatment of phrynoderma, various nutrients have been tried in different dosages and routes with variable therapeutic outcomes. A randomized controlled study was conducted in an outpatient dermatology department of a tertiary care hospital to compare the efficacy of vitamin A, vitamin B complex, essential fatty acids, and vitamin E. Majority of these studies were conducted in the early and middle part of the last century, and these observations were mainly based on therapeutic response in patients with phrynoderma.
What is clear from the literature is that phrynoderma responds to nutritional repletion; the evidence for dietary or supplemental interventions altering genetically-determined KP in well-nourished individuals is substantially weaker and largely anecdotal.
Herbs and Topical Natural Ingredients
Coconut Oil
Traditional/Folk Use: Coconut oil has a long history of traditional use across South and Southeast Asian cultures as a general skin emollient and moisturizer. Its topical use for rough, dry skin conditions predates modern dermatology.
Scientific Evidence: No clinical trials specifically investigating topical coconut oil for KP have been identified in the peer-reviewed literature. The relevant scientific evidence concerns coconut oil's effects on dry skin and related conditions. A randomized, double-blind controlled trial (Agero & Verallo-Rowell, 2004, Dermatitis) compared extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis (dry skin) and found coconut oil to be an effective moisturizer β relevant to KP given the central role of xerosis and barrier dysfunction in the condition. A separate randomized double-blind clinical trial (Evangelista et al., 2014, Int J Dermatol) examined topical virgin coconut oil in pediatric atopic dermatitis, a condition frequently co-occurring with KP, and found improvement in skin barrier measures including reduced transepidermal water loss. Evidence for coconut oil's direct impact on follicular hyperkeratosis in KP specifically is absent from the peer-reviewed record; existing use is based on its emollient and skin-barrier-supportive properties.
Lactic Acid (Naturally Derived)
Alpha hydroxy acids (AHAs), particularly glycolic acid and lactic acid, are water-soluble organic acids characterized by a single hydroxyl group attached to the Ξ±-carbon of the acid. These organic acids are commonly used in cosmetic formulations to remove thickened skin in hyperkeratotic disorders. Lactic acid occurs naturally in fermented foods and has been used as a keratolytic agent across many traditional cultures.
Scientific Evidence: Hydroxy acid-containing products are generally associated with improved exfoliation and increased moisturization. Collectively, these processes promote regulated exfoliation and restoration of normal epidermal turnover, highlighting the relevance of AHAs in disorders involving aberrant follicular keratinization, such as KP. A peer-reviewed literature review (published in PubMed/PMC, 2025β2026) concluded that topical keratolytics including AHAs, BHAs, and urea remain reasonable first-line, symptom-directed options for KP, all demonstrating potential benefit. However, the overall evidence base is constrained by small sample sizes, heterogeneous outcome measures, limited blinding, and short follow-up.
Urea
Urea is a naturally occurring compound and a component of the skin's natural moisturizing factor. Urea, a well-established ingredient in topical skincare, is a component of the natural moisturizing factors with concentration-dependent humectant, emollient, and exfoliative properties. Given the overlap of urea's properties and management goals of KP, a 4-week, open-label, noncomparative clinical study was conducted to evaluate a moisturizing cream formulated with 20% urea for use in KP. Thirty participants aged 18 to 65 years with KP completed this study. The most rapid response reported in published KP trials has been observed with 20% urea. Evidence strength is characterized as preliminary, drawn from small, mostly unblinded or noncomparative trials.
Glycolic Acid (Naturally Derived)
Glycolic acid is an alpha hydroxy acid (AHA) and the simplest of a variety of fruit acids useful as chemical exfoliants. Glycolic acid has an excellent capability to penetrate the skin, and is isolated from sugar cane, sugar beets, and unripe grapes. A patent-documented clinical evaluation found that a topical combination of buffered glycolic acid, urea, and tea extract demonstrated efficacy in significantly diminishing the appearance of keratosis pilaris by decreasing inflammation of the hair follicles and increasing skin hydration. This proprietary combination study does not constitute independent clinical evidence for glycolic acid alone.
Oatmeal (Avena sativa)
Traditional Use: Colloidal oatmeal has a long traditional history as a soothing, anti-inflammatory skin bath additive across European and North American folk medicine, used for a range of dry and inflamed skin conditions.
Scientific Evidence: Colloidal oatmeal is recognized by the U.S. FDA as a skin protectant ingredient for dry, itchy skin, based on its established soothing and barrier-protective properties. Its application to KP specifically has not been evaluated in dedicated peer-reviewed clinical trials; its use in KP is extrapolated from general evidence in xerosis and atopic dermatitis management.
Dietary and Lifestyle Factors
Dietary Patterns and Inflammatory Diet
Diet has been explored as a potential trigger, particularly in individuals with concurrent atopic conditions. High glycemic load and dairy intake have been implicated in worsening inflammatory skin conditions, though the evidence specific to keratosis pilaris is limited.
Because keratosis pilaris is inflammatory in nature, it makes sense that anti-inflammatory diet protocols might help KP. However, no controlled dietary intervention studies specifically targeting KP have been identified in the peer-reviewed literature, and this conclusion remains theoretical.
Malabsorption Syndromes and Gastrointestinal Disease
Keratosis pilaris can be caused by vitamin A deficiency or essential fatty acid deficiency, both of which can occur with gastrointestinal absorption problems. If you have celiac disease or gluten sensitivity, you are at risk of poor absorption. The mechanism is indirect: malabsorption of fat-soluble vitamins (particularly vitamin A) and essential fatty acids, secondary to intestinal disease, may produce or worsen follicular hyperkeratosis.
There are no studies indicating a direct correlation between gluten ingestion and keratosis pilaris. However, it can be caused by vitamin A deficiency or essential fatty acid deficiency, both of which can occur with impaired absorption. There is no definitive research specifically connecting keratosis pilaris and celiac disease or other gluten disorders, making it challenging to ascertain direct causation. The proposed link, where it exists, operates through the secondary pathway of nutrient malabsorption rather than any direct immunological mechanism specific to KP.
Hydration and Skin Barrier Maintenance
Environmental dryness and inadequate skin hydration are well-established aggravating factors for KP. Seasonal variation is described, with improvement in summer months. Dry skin in winter tends to worsen symptoms for some groups of patients. Maintaining skin hydration through internal fluid intake and external barrier-supportive practices is consistently referenced across dermatology literature as a cornerstone of management, though no quantitative hydration trials specific to KP are available.
Body Weight and Metabolic Lifestyle
Obesity has been implicated in a wide spectrum of dermatologic diseases, including KP. Skin affections were linearly associated with increasing BMI and higher age in a pediatric obesity cohort. KP was found in 64.7% of participants, and the HOMA score (insulin resistance measure) was significantly associated with KP (P = 0.019). The directionality of this association β whether metabolic dysfunction drives KP severity, or whether they share a common genetic background β remains unresolved.
Stress, Sleep, and Lifestyle
Lifestyle changes such as stress reduction, mindfulness techniques, and proper sleep hygiene might also improve KP by decreasing inflammation. While it is unlikely that studies will investigate these interventions soon, there is no reason that one cannot implement changes to decrease inflammation, which may have the additional benefit of improving keratosis pilaris. These suggestions are biologically plausible in the context of inflammatory skin conditions but are not supported by KP-specific controlled studies.
Summary of Evidence Strength
- Well-established: Genetic basis (filaggrin mutations, autosomal dominant inheritance); association with atopy, ichthyosis vulgaris, and dry skin; seasonal aggravation by low humidity.
- Moderate evidence (observational): Association between elevated BMI, insulin resistance, and increased KP prevalence; vitamin A deficiency as a cause of phrynoderma (nutritional follicular hyperkeratosis), which is morphologically similar to KP.
- Preliminary/weak evidence: Role of essential fatty acid deficiency in worsening KP in nutritionally replete individuals; efficacy of topical AHAs, urea, and keratolytics for symptom management (supported by small, heterogeneous trials).
- Anecdotal/no peer-reviewed evidence: Gluten elimination for KP in the absence of confirmed celiac disease or clinically significant malabsorption; dairy elimination; anti-inflammatory dietary patterns specifically for KP; topical coconut oil for KP lesions directly.
- Evidence gap: No randomized controlled trials exist examining oral nutritional supplementation (vitamin A, omega-3, vitamin E, or vitamin C) for genetically-determined keratosis pilaris in well-nourished populations.
References
- Pennycook KB, McCready TA. Keratosis Pilaris. StatPearls. NCBI Bookshelf (NIH).
- Alai NN. Keratosis Pilaris: Background, Pathophysiology, Etiology. Medscape/eMedicine.
- Wang JF, Orlow SJ. Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options. American Journal of Clinical Dermatology. 2018.
- Keratosis Pilaris Unveiled: Insights into its Origin, Management Strategies and Research Frontiers. PubMed/PMC. 2025.
- The Effectiveness of Topical Keratolytics (Alpha Hydroxy Acids/Beta Hydroxy Acids/Urea) in Treating Keratosis Pilaris: A Review of the Literature. PMC/PubMed. 2025β2026.
- Salava A, Salo V, Remitz A. Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis β Results of a Finnish cross-sectional study. PMC. 2022.
- Thomas M, Khopkar US. Keratosis Pilaris Revisited: Is It More Than Just a Follicular Keratosis? Int J Trichology. PMC. 2012.
- Schmitt JV et al. Keratosis pilaris and prevalence of acne vulgaris: A cross-sectional study. PMC/NIH. 2014.
- A Review of the Scoring and Assessment of Keratosis Pilaris. PMC. 2023.
- Hyperkeratosis. StatPearls. NCBI Bookshelf (NIH).
- A Clinical Study of 125 Patients with Phrynoderma. PMC/NIH. 2011.
- Therapeutic Response of Vitamin A, Vitamin B Complex, Essential Fatty Acids and Vitamin E in the Treatment of Phrynoderma: A Randomized Controlled Study. PMC. 2014.
- Pediatric obesity and skin disease: cutaneous findings and associated quality-of-life impairments in 103 children and adolescents with obesity. Endocrine Connections. 2023.
- Evaluating the Evidence for a Link Between Glycemic Control and Keratosis Pilaris in Type 2 Diabetes: A Systematic Review. International Medical Journal. 2025.
- The Link Between Obesity and the Skin. PMC. 2022.
- Ayers S, Mihan R. Synergism of vitamins A and E with dermatologic applications. PubMed.
- Atopic Dermatitis. StatPearls. NCBI Bookshelf (NIH).
- Burkhart A (MD, RD). Gluten and Keratosis Pilaris: Chicken Skin Rash. The Celiac MD.
- Evaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris. Journal of Drugs in Dermatology. 2024.
- Keratosis Pilaris Unveiled: Insights into its Origin, Management Strategies and Research Frontiers. PMC. 2025.
Go back